Volpara acquires breast cancer risk assessor for $23.6m
WELLINGTON: Breast cancer detection technology company Volpara has made its largest acquisition to date, buying
WELLINGTON: Breast cancer detection technology company Volpara has made its largest acquisition to date, buying